logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Distribution of clients entering treatment according to age at first use of primary drug and primary drug - EU overall summary in 2005 [see all tables in this series...]

Part (viii) Distribution of all inpatient clients by primary drug for each age group

Substance<1515-1920-2425-2930-3435-3940-4445+Age knownAge not known
Hypnotics and sedatives3.64.58.813.917.726.642.160.12405429
Volatile substances5.
Other substances


 Countries reporting data: BG, CZ, DK, DE, IE, EL, CY, LU, RO, SK, FI, SE, TR 

 The number of treatment clients in each country is listed in [Table TDI-7]. 

 See also 'TDI-109-All inpatient age at first use and primary drug.xls' on distribution by country and 'General notes for interpreting data' on the Explanatory notes and help page


 2006 Reitox national reports - Table TDI inpatient treatment centres. 

Page last updated: Monday, 12 November 2007